THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 146 filers reported holding THERAPEUTICSMD INC in Q1 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $12,000 | +9.1% | 30,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $11,000 | -54.2% | 30,500 | -6.2% | 0.00% | -50.0% |
| Q3 2021 | $24,000 | -44.2% | 32,500 | -10.8% | 0.00% | -33.3% |
| Q2 2021 | $43,000 | -8.5% | 36,450 | +3.3% | 0.00% | -25.0% |
| Q1 2021 | $47,000 | +14.6% | 35,300 | +2.3% | 0.00% | +33.3% |
| Q4 2020 | $41,000 | -51.2% | 34,500 | -35.3% | 0.00% | -62.5% |
| Q3 2020 | $84,000 | +25.4% | 53,300 | 0.0% | 0.01% | +14.3% |
| Q2 2020 | $67,000 | +21.8% | 53,300 | +1.5% | 0.01% | -12.5% |
| Q1 2020 | $55,000 | -57.0% | 52,500 | -1.5% | 0.01% | -38.5% |
| Q4 2019 | $128,000 | -15.8% | 53,300 | +27.8% | 0.01% | -23.5% |
| Q3 2019 | $152,000 | +508.0% | 41,700 | +317.0% | 0.02% | +466.7% |
| Q2 2019 | $25,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,660,108 | $60,749,000 | 7.08% |
| VHCP Management, LLC | 846,500 | $4,410,000 | 2.37% |
| Broadfin Capital, LLC | 2,128,159 | $11,088,000 | 1.46% |
| OUTFITTER ADVISORS, LTD. | 333,484 | $1,737,000 | 0.69% |
| GILDER GAGNON HOWE & CO LLC | 7,547,644 | $39,323,000 | 0.56% |
| Granite Point Capital Management, L.P. | 240,000 | $1,250,000 | 0.21% |
| EAM Investors, LLC | 221,885 | $1,156,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 135,208 | $704,000 | 0.14% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 70,000 | $365,000 | 0.06% |
| GAM Holding AG | 427,450 | $2,227,000 | 0.04% |